News

In Silico Drug Discovery Market Forecast, Revenue, Demand, Growth and Key Companies Valuation by 2028

September 15, 2021

The global In Silico Drug Discovery Market is forecasted to be worth USD 6.34 Billion by 2027, according to a current analysis by Emergen Research. The constant increase in the number of patients suffering from chronic diseases and pharmaceutical companies investing heavily in the development of various drugs are also influencing the market growth. The In silico drug discovery process help in the design and development of novel products. The report provides In Silico Drug Discovery market forecast, supported by detailed insights historical data and revenues, past and current market trends, industry trends, consumer trends, market size, market share, market growth, along with ranging impacts of each factor and driver. It also provides analysis of various factors expected to restrain or limit potential growth in market size over the forecast period, 2024–2028. The report includes profiles of major players in the market, strategies being employed, mergers, acquisitions, recent developments, agreements, contracts, new product development and launches, segment revenue, investment details as well as financials.

Download FREE Sample Brochure (Customized Sample PDF File delivered as per your specific requirement)@ https://www.emergenresearch.com/request-sample/373

Global In Silico Drug Discovery market forecast has been provided following thorough study, focus, comparison, and analysis of a varying range of factors and past market forecast and present outcomes. In Silico Drug Discovery Market forecast is made possible through, but has not been limited to, a study and analysis of a variety of factors and trends, and these are verified through interviews with industry experts and companies operating in the market.

Another market driving the demand for intelligent drug discovery will be the availability of various options to carry out the standard options such as customization capabilities and data mining on the AI platform. However, lack of data sets in drug discovery and scarcity of skilled professionals will hinder market demand.

Browse Full Report Description with TOC@ https://www.emergenresearch.com/industry-report/in-silico-drug-discovery-market

Incorporated with Info-graphics, charts, 70 tables and 85 figures, this 250-page research report “In Silico Drug Discovery Market Size, Type, Application, End-Use Industry, Regional Outlook, Competitive Strategies and Forecasts, 2024 – 2027” is based on a complete research of the entire Global market and covering all its sub-segments through comprehensively thorough classifications. Insightful analysis and assessment are created from superior primary and secondary information sources with data and information derived from industry specialists across the value chain.

Rising focus by major companies on product/service expansion into new and untapped domestic markets, increasing investments in strategic agreements, favourable government policies and regulations, and growing competition in the market are some major trends observed in the In Silico Drug Discovery market. Development of more advanced offerings is driving rising demand and deployment in respective sectors/industries, and this is expected to drive In Silico Drug Discovery market revenue growth to a significant extent over the forecast period.

Region wise performance of the In Silico Drug Discovery industry

North America In Silico Drug Discovery market forecast is expected to remain significantly positive in terms of revenue share between 2024 and 2028. In addition, North America In Silico Drug Discovery market revenue share is expected to remain comparatively larger than that of other regional markets from 2024 to 2028.

Asia Pacific registered fastest revenue CAGR in 2024, and the In Silico Drug Discovery market forecast is that this trend is expected to continue going ahead. Market forecast states that revenue share contribution from China, India, and South Korea is expected to remain robust till 2028.

Europe In Silico Drug Discovery market forecast is positive currently, with revenue growth expected to remain steady between 2024 and 2028. Robust focus on research and development initiatives by major firms and changing trends and demographics in countries in the region are some factors expected to continue to support In Silico Drug Discovery market growth.

Key Highlights From The Report

In November 2024, Lead Pharma announced its collaboration and license agreement with Roche for the development of oral small molecules for the treatment of a broad range of immune-mediated diseases. Lead Pharma is using in silico lab for their computational chemistry, bioinformatics, and data mining activities.
The in silico molecular techniques are gaining popularity to engineer antibodies. It is used for the design of antibodies, including structure modeling, antibody stability evaluation, antibody-antigen complex prediction, and allosteric effects in antibodies and functions.
Computer-aided drug methodologies are playing a crucial role in the discovery of the drugs. This method is used in limiting the usage of animal models in pharmaceutical research, aid in the design of innovative and safe drug candidates, and supporting pharmacologist and medicinal chemist.
Usage of information technology in drug discovery is witnessing lucrative growth in the Asia Pacific region due to a rise in R&D activities and development in the biotechnology and pharmaceutical sectors. Moreover, the presence of a significant patient pool will fuel the demand for better healthcare services, which will drive the demand for the market
Key participants include Certara USA, Inc., Albany Molecular Research Inc., Chemical Computing Group ULC, Charles River, Dassault System (Biovia), Collaborative Drug Discovery Inc., Evotec A.G., ICAGEN, Inc., GVK Biosciences Private Limited, and Novo Informatics Pvt. Ltd., among others.

Request customized copy of In Silico Drug Discovery report@ https://www.emergenresearch.com/request-for-customization/373

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:

United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:

North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

Table of Content

Chapter 1. Methodology & Sources

1.1. In Silico Drug Discovery Market Definition

1.2. Research Scope

1.3. Methodology

1.4. Research Sources

1.4.1. Primary

1.4.2. Secondary

1.4.3. Paid Sources

1.5. In Silico Drug Discovery Market Estimation Technique

Chapter 2. Executive Summary

2.1. Summary Snapshot, 2024-2028

Chapter 3. Key Insights

Chapter 4. In Silico Drug Discovery Market Segmentation & Impact Analysis

4.1. In Silico Drug Discovery Market Material Segmentation Analysis

4.2. Industrial Outlook

4.2.1. In Silico Drug Discovery Market indicators analysis

4.2.2. In Silico Drug Discovery Market drivers analysis

4.2.2.1. Rapid urbanization and industrialization

4.2.2.2. Stringent government regulations regarding carbon emissions

4.2.2.3. Increasing prevalence of respiratory diseases

4.2.2.4. Rising need to enhance indoor air quality

4.2.3. In Silico Drug Discovery Market restraints analysis

4.2.3.1. High cost associated with the maintenance of In Silico Drug Discovery products

4.2.3.2. Availability of renewable sources of energy

4.3. Technological Insights

4.4. Regulatory Framework

4.5. Porter’s Five Forces Analysis

4.6. Competitive Metric Space Analysis

4.7. Price trend Analysis

4.8. Covid-19 Impact Analysis

Chapter 10. Competitive Landscape

10.1. In Silico Drug Discovery Market Revenue Share By Manufacturers

10.2. Mergers & Acquisitions

10.3. Competitor’s Positioning

10.4. Strategy Benchmarking

10.5. Vendor Landscape

10.5.1. Raw Material Suppliers

10.5.1.1. North America

10.5.1.2. Europe

10.5.1.3. Asia Pacific

10.5.1.4. Middle East & Africa

10.5.1.5. Latin America

10.5.2. Distributors

10.5.2.1. North America

10.5.2.2. Europe

10.5.2.3. Asia Pacific

10.5.2.4. Middle East & Africa

10.5.2.5. Latin America

10.5.3. Others

Continued….

Avail Discount on In Silico Drug Discovery Market Report@ https://www.emergenresearch.com/request-discount/373

The research provides answers to the following key questions:

What will be the growth rate and the market size of the In Silico Drug Discovery industry for the forecast period 2024-2027?
What are the major driving forces expected to impact the development of the In Silico Drug Discovery market across different regions?
Who are the major driving forces expected to decide the fate of the In Silico Drug Discovery industry worldwide?
Who are the prominent market players making a mark in the In Silico Drug Discovery market with their winning strategies?
Which In Silico Drug Discovery industry trends are likely to shape the future of the industry during the forecast period 2024-2027?
What are the key barriers and threats believed to hinder the development of the industry?
What are the future opportunities in the In Silico Drug Discovery market?

Why Choose Emergen Research?